Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1994-11-07
1997-06-24
Wilson, James O.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514908, 536 274, 536 285, A61K 3170, C07H 1909
Patent
active
056417586
ABSTRACT:
Novel cytarabine derivatives of the formula ##STR1## where R.sup.1, R.sup.2 and R.sup.3, which can be identical or different, are each selected from the group consisting of hydrogen, aliphatic C.sub.2 -C.sub.5 -acyl, benzoyl or carboxy-C.sub.1 -C.sub.3 -alkylcarbonyl are described. The compounds are suitable for use directly or in the form of immunoliposomes for controlling diseases. Methods of preparing the novel cytarabine derivatives are also disclosed.
REFERENCES:
patent: 3894000 (1975-07-01), Wechter et al.
patent: 4022963 (1977-05-01), Deutsch
patent: 4772594 (1988-09-01), Hashimoto et al.
Schott et al., Liebigs Annalen der Chemie, vol. 1994, No. 5, pp. 465-470, May 1994.
Schwendener et al., Biochimica et Biophysica Acta., vol. 1026, pp. 69-79.
Divakar et al., J. of Chemical Society, Perkins Translation I, pp. 1171-1176, (1982).
Kluge Michael
Schott Herbert
LandOfFree
Cytarabine derivatives, the preparation and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cytarabine derivatives, the preparation and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytarabine derivatives, the preparation and use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-149200